Your browser is no longer supported. Please, upgrade your browser.
Panacea Acquisition Corp. II
Index- P/E- EPS (ttm)- Insider Own2.90% Shs Outstand17.80M Perf Week-0.40%
Market Cap177.95M Forward P/E- EPS next Y- Insider Trans105.65% Shs Float- Perf Month-0.20%
Income- PEG- EPS next Q- Inst Own31.23% Short Float- Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.02 Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.95 - 10.17 Perf YTD0.00%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-1.67% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low0.50% ATR0.04
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)- Volatility0.24% 0.36%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close10.00
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume175.78K Price10.00
Recom- SMA20-0.10% SMA50-0.10% SMA200-0.10% Volume53 Change0.00%
Panacea Acquisition Corp. II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EcoR1 Panacea Holdings II, LLCDirectorApr 09Buy10.00545,0005,450,000545,000Apr 13 03:10 PM